{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T13:12:12Z","timestamp":1724073132773},"reference-count":35,"publisher":"Centre for Evaluation in Education and Science (CEON\/CEES)","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/BY\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Biochemistry"],"published-print":{"date-parts":[[2023]]},"abstract":"<jats:p>Background: Lupus nephritis (LN) is one of the most serious complications in the development of systemic lupus erythematosus, that can adversely affect the course and prognosis of this autoimmune disease. Therefore, monitoring the effect of applied therapy, achieving remission, or monitoring class IV LN activity is still a great challenge for nephrologists. This study aimed to compare the urinary neutrophile gelatinase associated lipocalin (u\/NGAL) with traditionally accepted parameters for LNactivity to indicate the importance of its determination in these patients. Methods: The study group consisted of 40 patients with class IV LN, who were prospectively followed for a period of 4 months within three control visits to 2 months. The first group (20\/40) had active disease (Group A), and the second group had diseasein remission (Group B). The parameters we monitored and compared at each visit were standard biochemical parameters and kidney function parameters: C-reactive protein (CRP), blood count (CBC), creatinine, total proteins, albumin, cholesterol, triglycerides, glomerular filtration rate (eGFR). Regarding immune parameters, complement C3 and C4, antinuclear antibodies (ANA), anti-double stranded DNA antibody(anti ds DNA Ab) were monitored. Urine sediment, proteinuria 24h, urine culture, urinary protein\/creatinine ratio - Up\/Cre, and urinary NGAL (u\/NGAL) were monitored in Results: Comparing standard parameters of disease activity and u\/NGAL between groups, a statistically significant difference was obtained (p &lt; 0.001). Within Group A, comparing the parameters by visits (0 : 2) for anti-ds-DNA Ab a significance of p&lt; 0.05 was obtained, for albumin\/s and C3 a significance of p&lt;0.01 was obtained, and proteinuria\/24h, Up\/Cre, u\/NGAL had a significance of p &lt; 0.001. The mean level of u\/NGAL was elevated at the initially visit (173.25 \u00b1 172.12 ng\/mL), after two months 73.2 \u00b1 48.7 ng\/mL, and in the second visit a lower level was recorded (49.60 \u00b1 72.57 ng\/mL). The negative correlation of u\/NGAL was statistically significant at initial visit with albumin\/s (p&lt; 0.01) as well as the positive correlation with proteinuria 24h and Up\/Cre (p&lt; 0.001). In visit 2 significant negative correlation of u\/NGAL with albumin\/s and C3 p&lt; 0.05, and positive correlation with anti-ds-DNA Ab, proteinuria 24h and Up\/Cre p &lt; 0.001. Conclusions: The results of our study indicate that the level of u\/N GLA is elevated in patients with active Lupus nephritis class IV, as well as that it correlates with other parameters of disease activity. Serial determination of u\/NGAL could be significant in monitoring disease course and treatment<\/jats:p>","DOI":"10.5937\/jomb0-35933","type":"journal-article","created":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T08:08:04Z","timestamp":1659427684000},"page":"78-85","source":"Crossref","is-referenced-by-count":2,"title":["Comparison urine neutrophil gelatinase - associated lipocalin with standard parameters in monitoring activity Lupus nephritis: Class IV"],"prefix":"10.5937","volume":"42","author":[{"given":"Violeta","family":"Rabrenovi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milica","family":"Petrovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milorad","family":"Rabrenovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3964","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Morales E, Galindo M, Trujillo H, Praga M. Update on Lupus Nephritis: Looking for a New Vision. Nephron 2021; 145: 1-13;","DOI":"10.1159\/000511268"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Hsieh YP, Wen YK, Chen ML. The value of early renal biopsy in systemic lupus erythematosus patients presenting with renal involvement. Clin Nephrol 2012; 77(1): 18-24;","DOI":"10.5414\/CN107094"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Mahmood SN, Mukhtar KN, Deen S, Khan FN. Renal Biopsy: A much needed tool in patients with Systemic Lupus Erythematosis (SLE). Pak J Med Sci 2016; 32(1): 70-4;","DOI":"10.12669\/pjms.321.3386"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Malvar A, Alberton V, Lococo B, Ferrari M, Delgado P, Nagaraja HN,et al. Kidney biopsy-based management of maintenance immunosuppression is safe and may ameliorate flare rate in lupus nephritis. Kidney Int 2020; 97: 156-62;","DOI":"10.1016\/j.kint.2019.07.018"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Deonaraine KK, Carlucci PM, Fava A, Li J, Wofsy D, James JA, et al. Safety of procuring research tissue during a clinically indicated kidney biopsy from patients with lupus: data from the Accelerating Medicines Partnership RA\/SLE Network. Lupus Sci Med 2021; 8: e000522;","DOI":"10.1136\/lupus-2021-000522"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Khawaja S, Jafri L, Siddiqui I, Hashmi M, Ghani F. The utility of neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury (AKI) in critically ill patients. Biomark Res 2019; 22; 7:4;","DOI":"10.1186\/s40364-019-0155-1"},{"key":"ref7","unstructured":"Chen L, Zhang W. Kidney a-Intercalated Cells, NGAL and Urinary Tract Infection. Austin J Nephrol Hypertens 2014; 1(4): 1017;"},{"key":"ref8","unstructured":"Zhang CF, Wang HJ, Tong ZH, Zhang C, Wang ZS, Yang HQ, et al. The diagnostic and prognostic values of serum and urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin in sepsis induced acute renal injury patients. Eur Rev Med Pharmacol Sci 2020; 24(10): 5604-17;"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Lima C, de Paiva Haddad LB, de Melo PDV, Malbouisson LM, do Carmo LPF, D'Albuquerque LAC, et al. Early detection of acute kidney injury in the perioperative period of liver transplant with neutrophil gelatinase-associated lipocalin. BMC Nephrol 2019; 20(1): 367;","DOI":"10.1186\/s12882-019-1566-9"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Ralib AM, Pickering W, Shaw GM, Devarajan P, Edelstein CL, Bonventre JV, et al. Test Characteristics of Urinary Biomarkers Depend on Quantitation Method in Acute Kidney Injury. J Am Soc Nephrol 2012; 23: 322-33;","DOI":"10.1681\/ASN.2011040325"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Zhou F, Luo Q, Wang L, Han L. Diagnostic value of neutrophil gelatinase-associated lipocalin for early diagnosis of cardiac surgery-associated acute kidney injury: a meta-analysis. Eur J Cardiothorac Surg 2016; 49(3): 746-55;","DOI":"10.1093\/ejcts\/ezv199"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Kidher E, Harling L, Ashrafian H, Naase H, Chukwue - meka A, Anderson J,et al. Pulse wave velocity and neutrophil gelatinase-associated lipocalin as predictors of acute kidney injury following aortic valve replacement. J Cardiothorac Surg 2014; 9: 89;","DOI":"10.1186\/1749-8090-9-89"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Mussap M, Noto A, Fanos V, Van Den Anker JN. Emerging biomarkers and metabolomics for assessing toxic nephropathy and acute kidney injury (AKI) in neonatology. Biomed Res Int 2014; 2014: 602526;","DOI":"10.1155\/2014\/602526"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"He Y, Deng Y, Zhuang K, Li S, Xi J, Chen J. Predictive value of cystatin C and neutrophil gelatinase-associated lipocalin in contrast-induced nephropathy: A meta-analysis. PLoS One 2020; 15 (4): e0230934;","DOI":"10.1371\/journal.pone.0230934"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Banai A, Rozenfeld KL, Levit D, Merdler I, Loewenstein I, Banai S, Shacham Y. Neutrophil gelatinase-associated lipocalin (NGAL) for the prediction of acute kidney injury in chronic kidney disease patients treated with primary percutaneous coronary intervention. Int J Cardiol Heart Vasc 2020; 32: 100695;","DOI":"10.1016\/j.ijcha.2020.100695"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Corbac\u0131oglu SK, Cevik Y, Akinci E, Uzunosmanoglu H, Dagar S, Safak T, et al. Value of plasma neutrophil gelatinase-associated lipocalin (NGAL) in distinguishing between acute kidney injury (AKI) and chronic kidney disease (CKD). Turk J Emerg Med 2017; 2017(3): 85-8;","DOI":"10.1016\/j.tjem.2017.03.002"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Greenan-Barrett J, Doolan G, Shah D, Virdee S, Robin - son GA, Choida V, Gak N, de Gruijter N, Rosser E, Al-Obaidi M, Leandro M, Zandi MS, Pepper RJ, Salama A, Jury EC, Ciurtin C. Biomarkers Associated with Organ-Specific Involvement in Juvenile Systemic Lupus Erythe - matosus. Int J Mol Sci 2021; 22(14): 7619;","DOI":"10.3390\/ijms22147619"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Elewa EA, El Tokhy MA, Fathy SE, Talaat AM. Predictive role of urinary neutrophil gelatinase-associated lipocalin in lupus nephritis. Lupus 2015; 24(2): 138-46;","DOI":"10.1177\/0961203314550225"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7;","DOI":"10.1002\/art.1780251101"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40(9): 1725;","DOI":"10.1002\/art.1780400928"},{"key":"ref21","unstructured":"Churg J, Bernstein J, Glassock RJ. Lupus nephritis. En: Classification and Atlas of Glomerular Disease, 2nd ed. New York, Igaku-Shoin, 1995, p51;"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glome - rulonephritis in systemic lupus erithematous revisited. J Am Soc Nephrol 2004; 15: 241-50;","DOI":"10.1097\/01.ASN.0000108969.21691.5D"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Saxena R. Predicting kidney survival in lupus nephritis by adding clinical data to pathologic features. Kidney360 2022; 3(1): 5-7;","DOI":"10.34067\/KID.0007082021"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Touma Z, Urowitz MB, Taghavi-Zadeh S, Iba\u00f1ez D, Gladman DD. Systemic lupus erythematosus disease activity Index 2000 Responder Index 50: sensitivity to response at 6 and 12 months. Rheumatology (Oxford) 2012; 51(10): 1814-9;","DOI":"10.1093\/rheumatology\/kes146"},{"key":"ref25","unstructured":"Clinical and Laboratory Standards Institute (CLSI). User Verification of Performance for Precision and Trueness; Approved Guideline -Second Edition. CLSI Document EP15-A2. Wayne, PA: CLSI; 2005;"},{"key":"ref26","unstructured":"National Committee for Clinical Laboratory Standards (NCCLS). Protocols for Determination of Limits of Detection and Limits of Quantitation; Approved Guideline. NCCLS Document EP17-A. Wayne, PA: NCCLS; 2004;"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Rubinstein T, Pitashny M, Putterman C. The novel role of neutrophil gelatinase-B associated lipocalin (NGAL)\/ Lipocalin-2 as a biomarker for lupus nephritis. Auto - immun Rev 2008; 7(3): 229-34;","DOI":"10.1016\/j.autrev.2007.11.013"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Ding Y, Nie LM, Pang Y, Wu WJ, Tan Y, Yu F, Zhao MH. Composite urinary biomarkers to predict pathological tubulointerstitial lesions in lupus nephritis. Lupus 2018; 27(11): 1778-89;","DOI":"10.1177\/0961203318788167"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Brunner HI, Gulati G, Klein-Gitelman MS, Rouster-Stevens KA, Tucker L, Ardoin SP, et al. Urine biomarkers of chronic kidney damage and renal functional decline in childhood-onset systemic lupus erythematosus. Pediatr Nephrol 2019; 34(1): 117-28;","DOI":"10.1007\/s00467-018-4049-5"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Suzuki M, Wiers KM, Klein-Gitelman MS, Haines KA, Olson J, Onel KB, et al. Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis. Pediatr Nephrol 2008; 23(3): 403-12;","DOI":"10.1007\/s00467-007-0685-x"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Brunner HI, Mueller M, Rutherford C, Passo MH, Witte D, Grom A, et al. Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhoodonset systemic lupus erythematosus. Arthritis Rheum 2006; 54(8): 2577-84;","DOI":"10.1002\/art.22008"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Satirapoj B, Kitiyakara C, Leelahavanichkul A, Avihing - sanon Y, Supasyndh O. Urine neutrophil gelatinaseassociated lipocalin to predict renal response after in - duction therapy in active lupus nephritis. BMC Nephrol 2017; 18(1): 263;","DOI":"10.1186\/s12882-017-0678-3"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Yang CC, Hsieh SC, Li KJ, Wu CH, Lu MC, Tsai CY, Yu CL. Urinary neutrophil gelatinase-associated lipocalin is a potential biomarker for renal damage in patients with systemic lupus erythematosus. J Biomed Biotechnol 2012; 2012: 759313;","DOI":"10.1155\/2012\/759313"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Gao Y, Wang B, Cao J, Feng S, Liu B. Elevated urinary neutrophil gelatinase-associated lipocalin is a bio - marker for lupus nephritis: A systematic review and meta-analysis. Biomed Res Int 2020; 2020: 2768326;","DOI":"10.1155\/2020\/2768326"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"El-Mohsen MA, Tawfik A, Bichari W, Shawky S, Mady G, Hassan M. Value of urinary neutrophil gelatinase-associated lipocalin versus conventional biomarkers in predicting response to treatment of active lupus nephritis. Int J Nephrol 2020; 2020: 8855614. Received: April 17, 2022 Accepted: July 19, 2022;","DOI":"10.1155\/2020\/8855614"}],"container-title":["Journal of Medical Biochemistry"],"original-title":["Pore\u0111enje urinarnog lipokalina udru\u017eenog sa neutrofilnom gelatinazom i standardnih parametara za pra\u0107enje aktivnosti Lupus nefritisa - klasa IV"],"language":"en","link":[{"URL":"https:\/\/aseestant.ceon.rs\/index.php\/jomb\/article\/download\/35933\/20751","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/scindeks-clanci.ceon.rs\/data\/pdf\/1452-8258\/2023\/1452-82582301078R.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T19:02:15Z","timestamp":1674241335000},"score":1,"resource":{"primary":{"URL":"https:\/\/scindeks.ceon.rs\/Article.aspx?artid=1452-82582301078R"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.5937\/jomb0-35933","relation":{},"ISSN":["1452-8258","1452-8266"],"issn-type":[{"value":"1452-8258","type":"print"},{"value":"1452-8266","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]}}}